Gandhi, Shiv http://orcid.org/0000-0002-1850-187X
Klein, Jonathan http://orcid.org/0000-0002-3552-7684
Robertson, Alexander J. http://orcid.org/0000-0003-4607-4470
Peña-Hernández, Mario A.
Lin, Michelle J. http://orcid.org/0000-0002-6925-9948
Roychoudhury, Pavitra
Lu, Peiwen http://orcid.org/0000-0001-6118-872X
Fournier, John
Ferguson, David
Mohamed Bakhash, Shah A. K.
Catherine Muenker, M. http://orcid.org/0000-0002-0450-0868
Srivathsan, Ariktha
Wunder, Elsio A. Jr http://orcid.org/0000-0002-5239-8511
Kerantzas, Nicholas
Wang, Wenshuai
Lindenbach, Brett
Pyle, Anna
Wilen, Craig B. http://orcid.org/0000-0003-2495-9403
Ogbuagu, Onyema
Greninger, Alexander L.
Iwasaki, Akiko http://orcid.org/0000-0002-7824-9856
Schulz, Wade L. http://orcid.org/0000-0002-2048-4028
Ko, Albert I. http://orcid.org/0000-0001-9023-2339
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (2T32AI007517-21A1)
Article History
Received: 26 November 2021
Accepted: 28 February 2022
First Online: 17 March 2022
Competing interests
: A.L.G. reports institutional central testing contracts from Abbott and research grants from Merck and Gilead, outside of the proposed work. A.I.K. received consulting fees from Tata Sons and is the recipient of grants on COVID-19 from Merck, Regeneron and Serimmune, all of which are outside the submitted work. O.O. received consulting fees from Gilead and ViiV, as well as research support and honoraria from Gilead, outside of the submitted work. W.L.S. is a consultant for Hugo Health, founder of Refactor Health and is recipient of grants on COVID-19 from Merck and Regeneron, all of which are outside the submitted work. The remaining authors declare no competing interests.